Related content

Prognostic impact of pretreatment C-reactive protein for patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors

By Yasuda Yosuke   Saito Kazutaka   Yuasa Takeshi   Kitsukawa Shinichi   Urakami Shinji   Yamamoto Shinya   Yonese Junji   Takahashi Shunji   Fukui Iwao  

International Journal of Clinical Oncology, Vol. 18, Iss. 5, 2013-10 ,pp. : 884-889

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic outcome in patients treated with tyrosine kinase inhibitors as first-line molecular-targeted therapy for metastatic renal cell carcinoma: Experience in real-world clinical practice in Japan

By          

Molecular and Clinical Oncology, Vol. 3, Iss. 3, 2015-01 ,pp. : 601-606

Science Publishers

Access to resources Recommend Favorite

Expression of C-reactive protein and cyclooxygenase enzyme-2 in clear cell renal cell carcinoma: correlation with pathological parameters in 110 patients

By Ali Sarfraz  

Tumor Biology, Vol. 32, Iss. 2, 2011-04 ,pp. : 375-380

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of Survival Rates in Patients with Metastatic Renal Cell Carcinoma According to Treatment Era Including Cytokine and Targeted Therapy

By Takagi Toshio   Kondo Tsunenori   Kennoki Takafumi   Iizuka Jyunpei   Kobayashi Hirohito   Hashimoto Yasunobu   Tanabe Kazunari  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 4, 2013-04 ,pp. : 439-443

Oxford University Press

Access to resources Recommend Favorite

Association of high cost sharing and targeted therapy initiation among elderly Medicare patients with metastatic renal cell carcinoma

By  

Cancer Medicine, Vol. 7, Iss. 1, 2018-01 ,pp. : 75-86

John Wiley & Sons Inc

Access to resources Recommend Favorite